Loading clinical trials...
Loading clinical trials...
An Open-Label, Multiple-Dose, Non-Randomized Study to Assess the Drug-Drug Interactions of Proellex® (CDB-4124) With Cytochrome P450 Isoenzymes CYP1A2, 2C9, 2C19, 2D6, and 3A4 in Healthy Female Subjects
Conditions
Interventions
Proellex
CYP1A2 probe
+4 more
Locations
1
United States
Clinical Research Center Advanced Biomedical Research Inc.
Hackensack, New Jersey, United States
Start Date
July 1, 2008
Primary Completion Date
September 1, 2008
Completion Date
October 1, 2008
Last Updated
August 22, 2014
NCT07248826
NCT06159699
NCT03813875
NCT00621309
NCT02576366
NCT03748745
Lead Sponsor
Repros Therapeutics Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions